AVIDITY BIOSCI (RNA)
$26.08
0.66 (2.53%)
RNA Stock Quote Delayed 30 Minutes
RNA Stock Earnings: Avidity Biosciences Beats EPS, Misses Revenue for Q2 2024
RNA stock results show that Avidity Biosciences beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$29.52
Market Cap
3.21B
PE Ratio
-9.02
EPS
-2.8922
Volume (Avg. Vol.)
2.46M
Day's Range
$26.55 - $29.38
52-Week Range
$21.56 - $56.00
Dividend & Yield
N/A (N/A)
